Even when identical genes are involved, the impact of tissue heterogeneity on metabolic checkpoint therapy may be significant.
← all excerpts
Metabolic checkpoints in glioblastomas: targets for new therapies and non-invasive detection.
1
—
—
Even when identical genes are involved, the impact of tissue heterogeneity on metabolic checkpoint therapy may be significant.